Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia

Psychopharmacology

Volumn 157, Issue 3, 2001, Pages 284-291

  Hutton, S ^a   Crawford, T ^b   Gibbins, H ^a   Cuthbert, I ^a   Barnes, T ^a   Kennard, C ^a   Joyce, E ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Antipsychotic medication; Eye movement; Eye tracking; Schizophrenia; Smooth pursuit

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SCHIZOPHRENIA; SHORT COURSE THERAPY; SMOOTH PURSUIT EYE MOVEMENT; SYMPTOM; TIME; VELOCITY;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PURSUIT, SMOOTH; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS;

EID: 0034807636     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100803     Document Type: Article

References (44)

1. Quantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective-disorders
2. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
3. Smooth pursuit eye-movements, clinical symptoms, CSF metabolites, and skin-conductance habituation in schizophrenic-patients
4. Human smooth pursuit during transient perturbations of predictable target movement
5. Cortical networks subserving pursuit and saccadic eye movements in humans: An FMRI study
6. SPEM impairment in drug-naive schizophrenic-patients - Evidence for a trait marker
7. Psychophysiological measures of (dis)inhibition as liability indicators for schizophrenia
8. Smooth pursuit eye movement abnormalities in patients with schizophrenia and focal cortical lesions
9. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
10. Neuropsychological evidence for frontostriatal dysfunction in schizophrenia
11. Saccadic intrusions into smooth pursuit in patients with schizophrenia or affective-disorder and normal controls
12. Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia
13. Oculomotor and manual tracking in Parkinson's disease and the effect of treatment
14. The neuropathological effects of antipsychotic drugs
15. Eye tracking dysfunctions in schizophrenic patients and their relatives
16. Oculomotor abnormalities in schizophrenia: Critical review
17. Smooth pursuit and saccadic abnormalities in first-episode schizophrenia
18. Executive function in first-episode schizophrenia
19. Adverse neurobiological effects of long-term use of neuroleptics: Human and animal studies
20. Psychomotor impairment and cognitive disturbances induced by neuroleptics
21. Smooth pursuit eye-movements in schizophrenia - Influences of neuroleptic treatment and the question of specificity
22. Eye tracking dysfunction unrelated to clinical state and treatment with haloperidol
23. Eye tracking and schizophrenia - A selective review
24. Prospective study of psychobiology in first episode schizophrenia at Hillside Hospital
25. Smooth pursuit eye-movements in schizophrenia - Effects of neuroleptic treatment and caffeine
26. Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia
27. Effects of pharmacological catecholamine manipulation on smooth-pursuit eye-movements in normals
28. Lorazepam induced modifications of saccadic and smooth pursuit eye movements in humans: Attentional and motor factors
29. Functional neuroanatomy of smooth pursuit and predictive saccades
30. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage
31. Relationships between neuropsychological and oculomotor measures in schizophrenia patients and normal controls
32. The effects of age on a smooth pursuit tracking task in adults with schizophrenia and normal subjects
33. Amplitude criteria and anticipatory saccades during smooth pursuit eye movements in schizophrenia
34. Eye tracking performance in psychiatric patients
35. Smooth pursuit eye-movement disorder and its psychobiologic correlates in unmedicated schizophrenics
36. The effect of neuroleptics and tardive-dyskinesia on smooth-pursuit eye-movement in chronic-schizophrenics
37. Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia
38. Selective effects of antipsychotic medications on eye tracking performance in schizophrenia
39. Target anticipation and impairment of smooth pursuit eye movements in schizophrenia
40. Abnormalities of smooth eye and head movements control in Parkinson's disease
41. Oculomotor deficits in Parkinson's disease 2. Control of the saccadic and smooth pursuit systems